ADC Therapeutics Tumbles On Phase 3 Trial Safety Concerns, Joins Other Big Stocks Moving Lower In Thursday's Pre-Market Session (CORRECTED)
ADC Therapeutics plunges after patient deaths in blood cancer drug trial
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance